New mRNA vaccines aim to protect toddlers from two common winter viruses
⭐️ VACCINE ⭐️
Ongoing
This study tests two new mRNA vaccines in children aged 5 months to 2 years. One vaccine targets RSV alone, the other targets both RSV and hMPV—two viruses that can cause serious breathing problems in young kids. The main goal is to check safety and how well the vaccines trigger …
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:02 UTC